Evidence map›Paper›PMID 35531133›Full record

ArticleResearch in pharmaceutical sciences2022

Further evidence to support acute and chronic anti-inflammatory effects of

Mostafa Mostafazadeh, Heibatollah Sadeghi, Hossein Sadeghi, Vahid Zarezade, Abolghasem Hadinia, Esmaeel Panahi Kokhdan

Open access · goldAbstract read
In one paragraph

Article in Research in pharmaceutical sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mostafa MostafazadehDepartment of Biochemistry and Clinical Laboratories, Tabriz University of Medical Sciences, Tabriz, I.R. Iran.
Heibatollah SadeghiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Hossein SadeghiMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Vahid ZarezadeDepartment of Clinical Biochemistry, Faculty of Medicine, Behbahan University of Medical Sciences, Behbahan, I.R. Iran.
Abolghasem HadiniaCellular and Molecular Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Esmaeel Panahi KokhdanMedicinal Plants Research Center, Yasuj University of Medical Sciences, Yasuj, I.R. Iran.
Yasuj University of Medical Sciences · IRTabriz University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Previously, we reported the anti-inflammatory properties of Experimental approach: Folin-Ciocalteu and aluminum chloride methods were used to estimate the extract's total phenol and flavonoid content, respectively. Carrageenan-induced paw edema was carried out and TNF-α and IL-1β concentrations in the carrageenan-treated paw tissue were determined. Formalin injection into rat hind paws (7 days) and the application of 12-O-tetradecanoyl phorbol-13-acetate (TPA) on mouse ears (9 days) were used to simulate chronic inflammation. Furthermore, a histological assessment of the inflamed tissues was carried out. Findings/Results: The extract's flavonoid and phenolic contents were 90.26 ± 4.81 mg rutin equivalents/g and 68 ± 8.16 gallic acid equivalents/g gallic acid, respectively. Conclusion and implications: The data confirmed the topical and systemic anti-inflammatory effects of watercress against two chronic models of inflammation. They suggested that these properties are not related to TNF-α but could be attributed to inhibition of IL-1β and inhibition of leukocyte infiltration.

Indexed as

Anti-inflammatoryInterleukin-1 betaNasturtium officinaleTetradecanoyl phorbol acetateTumor necrosis factor-alpha

Identifiers

PMID35531133
PMCPMC9075025
OpenAlexW4226198645

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.